Y. Haliloglu Et Al. , "Characterization of cord blood CD3+TCRVα7.2+CD161high T and innate lymphoid cells in the pregnancies with gestational diabetes, morbidly adherent placenta, and pregnancy hypertension diseases," American Journal of Reproductive Immunology , vol.88, no.1, 2022
Haliloglu, Y. Et Al. 2022. Characterization of cord blood CD3+TCRVα7.2+CD161high T and innate lymphoid cells in the pregnancies with gestational diabetes, morbidly adherent placenta, and pregnancy hypertension diseases. American Journal of Reproductive Immunology , vol.88, no.1 .
Haliloglu, Y., ÖZCAN, A., Erdem, S., Azizoglu, Z. B., Bicer, A., Ozarslan, O. Y., ... KILIÇ, Ö.(2022). Characterization of cord blood CD3+TCRVα7.2+CD161high T and innate lymphoid cells in the pregnancies with gestational diabetes, morbidly adherent placenta, and pregnancy hypertension diseases. American Journal of Reproductive Immunology , vol.88, no.1.
Haliloglu, Yesim Et Al. "Characterization of cord blood CD3+TCRVα7.2+CD161high T and innate lymphoid cells in the pregnancies with gestational diabetes, morbidly adherent placenta, and pregnancy hypertension diseases," American Journal of Reproductive Immunology , vol.88, no.1, 2022
Haliloglu, Yesim Et Al. "Characterization of cord blood CD3+TCRVα7.2+CD161high T and innate lymphoid cells in the pregnancies with gestational diabetes, morbidly adherent placenta, and pregnancy hypertension diseases." American Journal of Reproductive Immunology , vol.88, no.1, 2022
Haliloglu, Y. Et Al. (2022) . "Characterization of cord blood CD3+TCRVα7.2+CD161high T and innate lymphoid cells in the pregnancies with gestational diabetes, morbidly adherent placenta, and pregnancy hypertension diseases." American Journal of Reproductive Immunology , vol.88, no.1.
@article{article, author={Yesim Haliloglu Et Al. }, title={Characterization of cord blood CD3+TCRVα7.2+CD161high T and innate lymphoid cells in the pregnancies with gestational diabetes, morbidly adherent placenta, and pregnancy hypertension diseases}, journal={American Journal of Reproductive Immunology}, year=2022}